Comparative Study of the Binding Properties of Cloned Human β1- and β2-Adrenergic Receptors Expressed in Escherichia coli W. H. M. L. LuytenP. J. PauwelsJ. E. Leysen Section 1 26 October 2012 Pages: 3 - 12
Animal Pharmacology of Nebivolol W. J. JanssensR. XhonneuxP. A. J. Janssen Section 1 26 October 2012 Pages: 13 - 24
Clinical Pharmacokinetics of Nebivolol A. Van PeerE. SnoeckJ. Heykants Section 1 26 October 2012 Pages: 25 - 30
Clinical Pharmacology of Nebivolol J. S. McLayN. IrvineD. G. McDevitt Section 1 26 October 2012 Pages: 31 - 32
Cardiovascular, Respiratory and Metabolic Effects of Nebivolol During Maximal and Submaximal Exercise Performance E. W. DermanM. HausT. D. Noakes Section 2 26 October 2012 Pages: 33 - 39
Noninvasive Cardiac Haemodynamics of Nebivolol J. De CréeH. GeukensH. Verhaegen Section 2 26 October 2012 Pages: 40 - 50
Effects of Nebivolol on Haemodynamics, Cardiac Dimensions and Function, Cardiovascular Reflexes and Biochemical Measures of Sympathetic Activity in Normal Human Subjects Garry JenningsM. EslerG. Eisenhofer Section 2 26 October 2012 Pages: 51 - 59
Invasive Haemodynamics of Nebivolol in Hypertensive Patients L. M. A. B. Van BortelP. M. H. SchiffersJ. M. V. Mooij Section 3 26 October 2012 Pages: 60 - 60
Nebivolol Improves the Vessel Wall Properties of the Common Carotid Artery L. M. A. B. Van BortelT. Van MerodeH. A. J. Struyker Boudier Section 3 26 October 2012 Pages: 61 - 63
Haemodynamic Effects of Nebivolol in Patients with Coronary Artery Disease Stephan BruneUlrich TebbeK.-U. Seiler Section 3 26 October 2012 Pages: 64 - 68
Pilot Study of Cardiovascular Effects of Nebivolol in Congestive Heart Failure Ph. LechatS. BoutelantY. Grosgogeat Section 3 26 October 2012 Pages: 69 - 81
Effect of Nebivolol on Survival of Cardiomyopathic Hamsters with Congestive Heart Failure Luc Ver DonckL. WoutersP. A. J. Janssen Section 3 26 October 2012 Pages: 82 - 85
Antianginal and Anti-Ischaemic Activity of Nebivolol in Stable Angina of Effort Angelo CherchiC. LaiE. Onnis Section 3 26 October 2012 Pages: 86 - 96
Results of a Pilot Study on the Tolerability of High-Dose Nebivolol in Essential Hypertension W. FlamenbaumP. WeberS. Giuetino Section 4 26 October 2012 Pages: 97 - 97
Effects of Nebivolol on Blood Pressure, Hormones and Cardiac Function in Chinese Subjects with Essential Hypertension Thomas Y. K. ChanK. S. WooM. G. Nicholls Section 4 26 October 2012 Pages: 98 - 104
Nebivolol in Hypertensive Patients L. M. A. B. Van BortelJ. JoostenJ. Mooij Section 4 26 October 2012 Pages: 105 - 106
Nebivolol Versus Metoprolol in the Treatment of Hypertension O. UhlířM. FejfušaK. Zeman Section 4 26 October 2012 Pages: 107 - 110
Differential Effects of Nebivolol on Adrenoceptors in the Heart and in Resistance Arterioles in the Rat W. LootsF. De Clerck Section 5 26 October 2012 Pages: 111 - 114
Differential Effects of Nebivolol, Atenolol and Propranolol on Heart Rate and Bronchoconstrictor Responses to Histamine in the Guinea-Pig F. De ClerckL. Van GorpP. A. J. Janssen Section 5 26 October 2012 Pages: 115 - 117
Nebivolol Induces Endothelium-Dependent Relaxations of Canine Arteries Yuansheng GaoTetsuhiko NagaoPaul M. Vanhoutte Section 5 26 October 2012 Pages: 118 - 119
The Receptor Binding Profile of the New Antihypertensive Agent Nebivolol and its Stereoisomers Compared with Various β-Adrenergic Blockers J. E. LeysenP. J. PauwelsP. A. J. Janssen Section 5 26 October 2012 Pages: 120 - 121
β-Adrenergic Receptor Coupled Adenylate Cyclase Activity in Living Cardiac Cells P. J. PauwelsJ. E. Leysen Section 5 26 October 2012 Pages: 122 - 122
β-Adrenoceptor Blocking Properties of dl-Nebivolol and its Enantiomers in the Pithed Normotensive Rat Jürgen SchneiderC. FruhT. Peters Section 5 26 October 2012 Pages: 123 - 128
Modulation of Isoprenaline-Induced Metabolic and Cardiovascular Responses in Dogs by Nebivolol, Atenolol and Propranolol Charles R. BowdenCarol S. Marchione Section 5 26 October 2012 Pages: 129 - 130
Antihypertensive Effects of Oral Nebivolol in the Conscious Dog with 2-Kidney, 1-Wrapped Perinephritic Hypertension Linda GamboneSiu Po Sit Section 5 26 October 2012 Pages: 131 - 133
Cytoprotective Effects of Nebivolol G. VandeplasscheL. Ver DonckM. Borgers Section 5 26 October 2012 Pages: 134 - 136
The Interaction of Nebivolol with Vascular Presynaptic β-Adrenoceptors in the Freely Moving Rat J. X. M. van RossumV. I. TarizzoJ. Zaagsma Section 5 26 October 2012 Pages: 137 - 139
Comparison of Left Ventricular Haemodynamics of Nebivolol and Metoprolol in Patients with Acute Myocardial Infarction J. De CréeA. Van RossumH. Verhaegen Section 5 26 October 2012 Pages: 140 - 141
The Effect of Nebivolol in Patients with Left Ventricular Diastolic Dysfunction J. De CréeJ. VanweldenH. Verhaegen Section 5 26 October 2012 Pages: 142 - 143
Influence of Nebivolol on Cardiovascular Haemodynamics During Postural Changes and Isometric Exercise D. DuprezR. LefebvreD. L. Clement Section 5 26 October 2012 Pages: 144 - 145
Cardiac Haemodynamics with Nebivolol and Metoprolol in Patients with Essential Hypertension P. HavránekZ. Stepanek Section 5 26 October 2012 Pages: 146 - 151
Nebivolol P. J. BlankestijnA. H. van den MeirackerM. A. D. H. Schalekamp Section 5 26 October 2012 Pages: 152 - 154
Effects of Nebivolol on Left Ventricular Function in Patients with Essential Hypertension Ramiro A. SanchezTomas CianciulliEnrique J. Marco Section 5 26 October 2012 Pages: 155 - 160
Haemodynamic Effects of Nebivolol in Poor and Extensive Metabolisers P. Van RooyJ. De Crée Section 5 26 October 2012 Pages: 161 - 163
Comparison of the Effects of Nebivolol and Metoprolol on Left Ventricular Diastolic Function in Patients with Hypertension J. VojáčekK. Kolář Section 5 26 October 2012 Pages: 164 - 166
Evaluation of Cardiac Function with Radionuclide Angiography in Hypertension J. A. SaavedraA. I. SantosCarlos Ribeiro Section 5 26 October 2012 Pages: 167 - 169
β-Blocking Capacity of Nebivolol Compared with Atenolol S. BygdemanB. LundgrenS. Rosfors Section 5 26 October 2012 Pages: 170 - 172
β-Adrenoceptor Blockade and β1 -Selectivity of Nebivolol and Atenolol L. M. A. B. Van BortelM. J. F. KoolH. A. J. Struyker Boudier Section 5 26 October 2012 Pages: 173 - 173
Exercise Tolerance with Nebivolol and Atenolol L. M. A. B. Van BortelM. A. van Baak Section 5 26 October 2012 Pages: 176 - 176
Dose-Dependent β-Sympatholytic Activity of Nebivolol in Comparison with Atenolol D. TrenkM. BuschmannE. Jähnchen Section 5 26 October 2012 Pages: 177 - 179
Long Term Therapy with Nebivolol in Patients with Hypertension Carlos CoboL. Alcocer Section 5 26 October 2012 Pages: 180 - 182
A Study to Assess the Effects of Nebivolol on Sedation and Psychomotor Performance in Normal Volunteers C. IdzikowskiS. GouldS. Downes Section 5 26 October 2012 Pages: 183 - 185
β-Blockade Prevents the Adverse Effects of Acute Stress I. JamesS. JordanS. E. Gould Section 5 26 October 2012 Pages: 186 - 187
Effects of Nebivolol on Dynamic Exercise in Patients with Hypertension A. P. MachadoC. MoreiraJ. A. Saavedra Section 5 26 October 2012 Pages: 188 - 189
Nebivolol in Hypertension G. SiebenL. Van NuetenJ. Symoens Section 5 26 October 2012 Pages: 190 - 192
Nebivolol in Hypertension G. SiebenL. Van NuetenJ. Symoens Section 5 26 October 2012 Pages: 193 - 195
Effects of Nebivolol, Atenolol and Propranolol on Airway β-Adrenergic Responsiveness in Normal Subjects A. F. MohammedG. HulksS. E. Gould Section 5 26 October 2012 Pages: 196 - 198
A Single-Blind Dose-Ranging Study of the Effect of Nebivolol in Patients with Angina Pectoris Göran Ulvenstam Section 5 26 October 2012 Pages: 199 - 200